The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan-Reference-Cited by-同舟云学术

The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan

Published:2017-06-01 Issue:6 Volume:12 Page:e0178035
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lim Chong Hong,Chen Hsin-Hua,Chen Yi-Hsing,Chen Der-Yuan,Huang Wen-Nan,Tsai Jaw-Ji,Hsieh Tsu-Yi,Hsieh Chia-Wei,Hung Wei-Ting,Lin Ching-Tsai,Lai Kuo-Lung,Tang Kuo-Tung,Tseng Chih-Wei,Chen Yi-Ming^ORCID

Funder

Taichung Veterans General Hospital

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference32 articles.

1. WHO. Global tuberculosis report 2016. 20th edition. http://www.who.int/tb/publications/global_report/en/.

2. Centers for Disease Control MoHaW, R.O.C.(Taiwan). Taiwan CDC Joins Hands With Industry, Government, And Academia To Reveal Accomplishments Of 10 Year Battle Against Tuberculosis (TB) With A Renewed Commitment To Eliminating The Disease. 2016. Web. 17 Nov. 2016.

3. Increased risk of tuberculosis in patients with rheumatoid arthritis;L Carmona;The Journal of rheumatology,2003

4. Immunity against Mycobacterium tuberculosis and the risk of biologic anti-TNF-α reagents;K Yasui;Pediatr Rheumatol Online J,2014

5. Immunological control of tuberculosis: role of tumour necrosis factor and more;S Stenger;Annals of the rheumatic diseases,2005

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The risk of tuberculosis infection in Saudi patients receiving adalimumab, etanercept, and tocilizumab therapy;Journal of Infection and Public Health;2024-06

2. A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritis;Expert Opinion on Drug Safety;2024-05-23

3. Drug Persistence and Incidence of Active Tuberculosis of Tumor Necrosis Factor Alpha Inhibitors Versus Tocilizumab as the First-Line Biological Treatment in Patients with Rheumatoid Arthritis: A Nationwide Population-Based Retrospective Cohort Analysis;Rheumatology and Therapy;2024-05-20

4. Repurposing of anti-malarial drugs for the treatment of tuberculosis: realistic strategy or fanciful dead end?;Malaria Journal;2024-05-03

5. Elderly-onset rheumatoid arthritis — clinical findings and treatment features (systematic literature review);PAIN, JOINTS, SPINE;2024-04-30